Published in Front Genet on November 09, 2012
Epigenetics, microRNA, and addiction. Dialogues Clin Neurosci (2014) 0.85
Profile of cerebrospinal microRNAs in fibromyalgia. PLoS One (2013) 0.84
Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute simian immunodeficiency virus infection of rhesus macaques. J Virol (2014) 0.83
MicroRNAs in opioid addiction: elucidating evolution. Front Genet (2012) 0.81
Whole-genome expression profile in zebrafish embryos after chronic exposure to morphine: identification of new genes associated with neuronal function and mu opioid receptor expression. BMC Genomics (2014) 0.78
Coinciding revolutions: how discovery of non-coding DNA and RNA can change our understanding of addiction. Front Genet (2012) 0.77
Dose-dependent effects of morphine exposure on mRNA and microRNA (miR) expression in hippocampus of stressed neonatal mice. PLoS One (2015) 0.75
The functions of animal microRNAs. Nature (2004) 64.85
A microRNA polycistron as a potential human oncogene. Nature (2005) 40.21
Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2008) 37.16
Identification of tissue-specific microRNAs from mouse. Curr Biol (2002) 34.55
The impact of microRNAs on protein output. Nature (2008) 32.39
Widespread changes in protein synthesis induced by microRNAs. Nature (2008) 31.44
Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature (2005) 17.17
Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev (2006) 15.20
Endogenous human microRNAs that suppress breast cancer metastasis. Nature (2008) 14.37
MicroRNA-133 controls cardiac hypertrophy. Nat Med (2007) 11.68
MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A (2007) 11.42
microRNA target predictions in animals. Nat Genet (2006) 10.76
A brain-specific microRNA regulates dendritic spine development. Nature (2006) 10.18
A MicroRNA feedback circuit in midbrain dopamine neurons. Science (2007) 8.33
Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature (2007) 7.04
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer (2006) 6.39
MicroRNA control of signal transduction. Nat Rev Mol Cell Biol (2010) 5.74
Isolation of microRNA targets by miRNP immunopurification. RNA (2007) 5.50
Concern Substrate requirements for let-7 function in the developing zebrafish embryo. Nucleic Acids Res (2004) 4.50
Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med (2007) 4.48
Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J (2010) 4.47
Retracted The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci (2007) 4.09
MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One (2007) 3.96
Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci (2011) 3.69
MicroRNA 29b functions in acute myeloid leukemia. Blood (2009) 3.19
miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer (2010) 3.14
Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem (2008) 3.00
Prediction and validation of microRNAs and their targets. FEBS Lett (2005) 2.99
Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci (2009) 2.96
Evolution of microRNA diversity and regulation in animals. Nat Rev Genet (2011) 2.92
Rho signaling pathway targeted to promote spinal cord repair. J Neurosci (2002) 2.90
Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence. Arch Gen Psychiatry (2007) 2.79
Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci (2003) 2.76
Opioid receptors. Annu Rev Biochem (2004) 2.71
Molecular mechanisms of drug addiction. Neuropharmacology (2004) 2.69
Striatal microRNA controls cocaine intake through CREB signalling. Nature (2010) 2.56
Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer (2009) 2.32
Muscle specific microRNAs are regulated by endurance exercise in human skeletal muscle. J Physiol (2010) 2.16
75 years of opioid research: the exciting but vain quest for the Holy Grail. Br J Pharmacol (2006) 1.91
MicroRNA function in neuronal development, plasticity and disease. Biochim Biophys Acta (2008) 1.84
microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget (2012) 1.83
The impact of miRNA target sites in coding sequences and in 3'UTRs. PLoS One (2011) 1.82
Context-dependent functions of specific microRNAs in neuronal development. Neural Dev (2010) 1.74
Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int J Cancer (2008) 1.72
MicroRNA profiling and head and neck cancer. Comp Funct Genomics (2009) 1.68
Drug addiction: a model for the molecular basis of neural plasticity. Neuron (1993) 1.62
MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Biochem Biophys Res Commun (2009) 1.58
miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget (2010) 1.53
Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology (2003) 1.51
miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. Int J Oncol (2011) 1.41
Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer. Cancer Res (2011) 1.40
miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo. Cancer Biol Ther (2010) 1.37
Attenuation of morphine tolerance and dependence with the highly selective delta-opioid receptor antagonist TIPP[psi]. Eur J Pharmacol (1995) 1.34
Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor. J Neurosci (2010) 1.29
Differential miRNA expression profiles in bladder urothelial carcinomas. Asian Pac J Cancer Prev (2010) 1.26
Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. Am J Pathol (2010) 1.25
Down-regulation of miR-133a contributes to up-regulation of Rhoa in bronchial smooth muscle cells. Am J Respir Crit Care Med (2009) 1.25
MicroRNA delivery by cationic lipoplexes for lung cancer therapy. Mol Pharm (2011) 1.25
Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle. BMC Dev Biol (2011) 1.24
Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma. Int J Oncol (2011) 1.24
Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor. J Investig Med (2002) 1.23
Role of delta-opioid receptor function in neurogenesis and neuroprotection. J Neurochem (2006) 1.23
Opioid and opiate immunoregulatory processes. Crit Rev Immunol (1996) 1.19
A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity. Oncotarget (2011) 1.19
Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs. J Neuroimmune Pharmacol (2006) 1.19
Morphine regulates dopaminergic neuron differentiation via miR-133b. Mol Pharmacol (2010) 1.18
Cytoplasmic p21(Cip1/WAF1) enhances axonal regeneration and functional recovery after spinal cord injury in rats. Neuroscience (2004) 1.18
mu-Opioid receptor agonists differentially regulate the expression of miR-190 and NeuroD. Mol Pharmacol (2009) 1.18
Endogenous opioids and addiction to alcohol and other drugs of abuse. Curr Top Med Chem (2009) 1.18
Differential expression of microRNAs in mouse pain models. Mol Pain (2011) 1.15
Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system. J Cell Biochem (2010) 1.13
MicroRNA function and mechanism: insights from zebra fish. Cold Spring Harb Symp Quant Biol (2006) 1.11
Yin Yang 1 phosphorylation contributes to the differential effects of mu-opioid receptor agonists on microRNA-190 expression. J Biol Chem (2010) 1.11
MicroRNA miR-133b is essential for functional recovery after spinal cord injury in adult zebrafish. Eur J Neurosci (2011) 1.10
Expression and function of nr4a2, lmx1b, and pitx3 in zebrafish dopaminergic and noradrenergic neuronal development. BMC Dev Biol (2007) 1.08
A 29-amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity, and reinnervation. FASEB J (2008) 1.08
Mu- and kappa-opioids induce the differentiation of embryonic stem cells to neural progenitors. J Biol Chem (2006) 1.08
Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes. Am J Pathol (2010) 1.08
Long-term morphine treatment decreases the association of mu-opioid receptor (MOR1) mRNA with polysomes through miRNA23b. Mol Pharmacol (2009) 1.04
Methadone enhances human immunodeficiency virus infection of human immune cells. J Infect Dis (2001) 1.04
Modulations of NeuroD activity contribute to the differential effects of morphine and fentanyl on dendritic spine stability. J Neurosci (2010) 1.02
Opioid-induced proliferation through the MAPK pathway in cultures of adult hippocampal progenitors. Mol Cell Neurosci (2003) 1.02
Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sci (1993) 1.02
miRNA signature of schwannomas: possible role(s) of "tumor suppressor" miRNAs in benign tumors. Oncotarget (2011) 1.01
RhoA, RhoB, RhoC, Rac1, Cdc42, and Tc10 mRNA levels in spinal cord, sensory ganglia, and corticospinal tract neurons and long-lasting specific changes following spinal cord injury. J Comp Neurol (2005) 1.00
Potentially predictive microRNAs of gastric cancer with metastasis to lymph node. World J Gastroenterol (2011) 0.99
The modulation of microRNAs by type I IFN through the activation of signal transducers and activators of transcription 3 in human glioma. Mol Cancer Res (2009) 0.98
Post-transcriptional regulation of mouse mu opioid receptor (MOR1) via its 3' untranslated region: a role for microRNA23b. FASEB J (2008) 0.98
Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. J Immunol (1987) 0.98
Mu opioid receptor from the zebrafish exhibits functional characteristics as those of mammalian mu opioid receptor. Zebrafish (2009) 0.97
Expression of miRNAs miR-133b and miR-206 in the Il17a/f locus is co-regulated with IL-17 production in αβ and γδ T cells. PLoS One (2011) 0.95
Small non-coding RNAs as novel therapeutics. Curr Mol Med (2010) 0.95
New insights into the roles of microRNAs in drug addiction and neuroplasticity. Genome Med (2010) 0.95
Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity. Psychopharmacology (Berl) (2009) 0.95
Characterization of ZFOR1, a putative delta-opioid receptor from the teleost zebrafish (Danio rerio). Neurosci Lett (2000) 0.93
CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone. Brain Res Bull (1995) 0.92
Thyroid hormone may regulate mRNA abundance in liver by acting on microRNAs. PLoS One (2010) 0.91
MicroRNAs in addiction: adaptation's middlemen? Mol Psychiatry (2011) 0.91